Patent details

EP3749353 Title: NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION

Basic Information

Publication number:
EP3749353
PCT Application Number:
IB2019051051
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197104888
PCT Publication Number:
WO2019155427
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION
French Title of Invention:
LE NÉMOLIZUMAB DANS LE TRAITEMENT DE LA DERMATITE ATOPIQUE À EXCORIATION MODÉRÉE À GRAVE
German Title of Invention:
NEMOLIZUMAB ZUR BEHANDLUNG VON ATOPISCHER DERMATITIS MIT MÄSSIGER BIS STARKER EXKORIATION
SPC Number:

Dates

Filing date:
08/02/2019
Grant date:
30/07/2025
EP Publication Date:
16/12/2020
PCT Publication Date:
15/08/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/07/2025
EP B1 Publication Date:
30/07/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/02/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/07/2025
 
 

Name:
Chugai Seiyaku Kabushiki Kaisha
Address:
5-1, Ukima 5-chome, Kita-ku Tokyo 115-8543, Japan (JP)

Name:
Galderma Holding SA
Address:
Rue d'Entre-deux-Villes, 10, 1814 La Tour-de-Peilz, Switzerland (CH)

Agent

Name:
NLO
From:
01/08/2025
Address:
P.O. Box 29720, 2502 LS The Hague, Netherlands (NL)
To:

Inventor

1

Name:
HIROKAWA, Keiko
Address:
Japan (JP)

2

Name:
MIHARA, Ryosuke
Address:
Japan (JP)

3

Name:
KERROUCHE, Nabil
Address:
France (FR)

Priority

Priority Number:
201862628714 P
Priority Date:
09/02/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61P 17/04; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:
202531
Publication date:
30/07/2025
Description:
Grant (B1)

2

Issue number:
202534
Publication date:
20/08/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
01/08/2025 Power Of Attorney 1
04/08/2025 Outgoing Correspondence 1